39 related articles for article (PubMed ID: 22849846)
1. Icodextrin-induced acute generalized exanthematous pustulosis in a patient with peritoneal dialysis.
Liu CH; Chen CC; Sung CC
Nephrology (Carlton); 2024 Jul; 29(7):442-445. PubMed ID: 38599621
[TBL] [Abstract][Full Text] [Related]
2. High Osmol Gap Hyponatremia Caused by Icodextrin: A Case Series Report.
de Fijter CWH; Stachowska-Pietka J; Waniewski J; Lindholm B
Am J Nephrol; 2024; 55(2):202-205. PubMed ID: 37579741
[TBL] [Abstract][Full Text] [Related]
3. Role of skin autofluorescence in managing renal and cardiac diseases in outpatient dermatology.
Etaee F; Naguib T; Goldust M; Daveluy S; Maibach H
Skin Res Technol; 2022 Nov; 28(6):889-905. PubMed ID: 36305176
[TBL] [Abstract][Full Text] [Related]
4. Dialysis Procedures Alter Metabolic Conditions.
Stegmayr B
Nutrients; 2017 May; 9(6):. PubMed ID: 28554992
[TBL] [Abstract][Full Text] [Related]
5. Skin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.
Mácsai E; Benke A; Kiss I
Medicine (Baltimore); 2015 Nov; 94(45):e1933. PubMed ID: 26559261
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal dialysis and inflammation.
Velloso MS; Otoni A; de Paula Sabino A; de Castro WV; Pinto SW; Marinho MA; Rios DR
Clin Chim Acta; 2014 Mar; 430():109-14. PubMed ID: 24333488
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
[TBL] [Abstract][Full Text] [Related]
8. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
[TBL] [Abstract][Full Text] [Related]
9. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
10. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
[TBL] [Abstract][Full Text] [Related]
11. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing skin autofluorescence of patients with peritoneal dialysis.
Mácsai E; Benke A; Cseh A; Vásárhelyi B
Acta Physiol Hung; 2012 Jun; 99(2):216-22. PubMed ID: 22849846
[TBL] [Abstract][Full Text] [Related]
13. Is the measurement of tissue advanced glycosylation products by skin autofluorescence associated with mortality in patients treated by peritoneal dialysis?
Vareesangthip K; Fan S; Davenport A
J Nephrol; 2023 Jan; 36(1):217-224. PubMed ID: 35980536
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
